M. Cerra

发表

Flavopiridol enhances human tumor cell radiosensitivity and prolongs expression of gammaH2AX foci.

K. Camphausen, P. Tofilon, W. Burgan, 2004, Molecular cancer therapeutics.

Transcriptional signature of flavopiridol-induced tumor cell death.

Kevin Camphausen, Mong-Hsun Tsai, Eric Y Chuang, 2004, Molecular cancer therapeutics.

Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid

K. Camphausen, H. Fine, T. Scott, 2005, International journal of cancer.

First‐in‐human study of milvexian, an oral, direct, small molecule factor XIa inhibitor

M. Cerra, D. Seiffert, J. Luettgen, 2021, Clinical and translational science.

Enhanced Tumor Cell Radiosensitivity and Abrogation of G2 and S Phase Arrest by the Hsp90 Inhibitor 17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin

K. Camphausen, P. Tofilon, W. Burgan, 2004, Clinical Cancer Research.

Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity.

K. Camphausen, P. Tofilon, W. Burgan, 2003, Cancer research.

Enhancement of In vitro and In vivo Tumor Cell Radiosensitivity by the DNA Methylation Inhibitor Zebularine

K. Camphausen, P. Tofilon, W. Burgan, 2005, Clinical Cancer Research.

Pharmacokinetic-pharmacodynamic modeling of antibacterial activity of cephalexin on E. coli in presence of canine serum

M. Cerra, E. Formentini, U. Notaro, 2012 .

Enhanced Radiation-Induced Cell Killing and Prolongation of γH2AX Foci Expression by the Histone Deacetylase Inhibitor MS-275

K. Camphausen, P. Tofilon, J. Trepel, 2004, Cancer Research.

PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation

D. Newby, M. Cerra, Simon J. Wilson, 2017, Arteriosclerosis, thrombosis, and vascular biology.